Wei-Ju Chen Selected Research

Wei-Ju Chen Research Topics

4	Human Influenza (Influenza) 01/2021 - 06/2015
3	Infections 01/2017 - 06/2015
2	Carcinogenesis 03/2021 - 01/2017
1	Demyelinating Diseases (Demyelinating Disease) 01/2022
1	Melanoma (Melanoma, Malignant) 03/2021
1	Neoplasms (Cancer) 03/2021
1	Autistic Disorder (Autism) 01/2019
1	Soft Tissue Infections 02/2015
1	Meningitis 02/2014
1	Pneumonia (Pneumonitis) 02/2014
1	Measles 04/2011
1	Hemorrhagic Shock 05/2007
1	X-linked Reticuloendotheliosis 06/2006
1	Severe Acute Respiratory Syndrome 11/2005

3	VaccinesIBA 12/2015 - 04/2011
2	Biological ProductsIBA 01/2019 - 04/2011
2	NF-kappa B (NF-kB)IBA 05/2007 - 06/2006
1	CuprizoneIBA 01/2022
1	chlorbensideIBA 03/2021
1	Mitoxantrone (Novantrone)FDA LinkGeneric 03/2021
1	Plasminogen Activators (Plasminogen Activator)IBA 03/2021
1	Plasminogen Activator Inhibitor 1IBA 03/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Prostaglandins AIBA 01/2018
1	DEAD-box RNA HelicasesIBA 01/2017
1	RNA Helicases (RNA Helicase)IBA 01/2017
1	Influenza Vaccines (Influenza Vaccine)FDA Link 12/2015
1	Neuraminidase (Sialidase)IBA 06/2015
1	ChlorhexidineIBA 02/2015
1	Conjugate VaccinesIBA 02/2014
1	Indicators and Reagents (Reagents)IBA 04/2011
1	SolutionsIBA 05/2007
1	Starch (Cornstarch)IBA 05/2007
1	CytokinesIBA 05/2007
1	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2007
1	Fibrinogen (Factor I)FDA Link 06/2006
1	Proteins (Proteins, Gene)FDA Link 06/2006
1	InterleukinsIBA 06/2006
1	Neutralizing AntibodiesIBA 11/2005

2	Therapeutics 01/2022 - 03/2021
1	Drug Therapy (Chemotherapy) 03/2021
1	Highly Active Antiretroviral Therapy (HAART) 01/2021
1	Resuscitation 05/2007